a:head bio
Business Description a:head’s drug discovery approach is based on human cerebral organoids, a revolutionary, paradigm-shifting new technology that allows the generation of mini brains from human stem cells in vitro. They capture the essential aspects of human embryonic brain development including brain patterning, formation of brain ventricles, differentiation into the various neuronal and supportive cell types and their correct three-dimensional arrangement. The technology has been pioneered by the company’s co-founders Madeline Lancaster and Juergen Knoblich and is exclusively licensed to a:head by the Institute of Molecular Biotechnology, Vienna, Austria.
Tags Pharmaceutical Manufacturing, Biotechnology, Drug Discovery
Website https://aheadbio.com/
Articles about a:head bio:
💡 You're a corporate or investor and looking for startups that are innovating in the same market as
a:head bio? We're happy to assist you with our
Startup Sourcing service.